First-in-human, phase I study of PF-06647263, an anti-EFNA4 calicheamicin antibody-drug conjugate, in patients with advanced solid tumors
2019 ◽
Vol 145
(7)
◽
pp. 1798-1808
◽
Keyword(s):
Phase I
◽
2018 ◽
Vol 36
(15_suppl)
◽
pp. 5565-5565
◽